In addition to effectively treating a resistant case of atopic dermatitis, the eczema drug dupilumab (Dupixent, Regeneron Pharmaceutics) triggered hair growth in a young patient with longstanding ...
Baricitinib demonstrated significant efficacy in severe alopecia areata, with over 50% achieving substantial hair regrowth within a year. Early intervention and patient selection, particularly those ...
Early phototherapy initiation within one year of alopecia areata onset significantly improves hair regrowth outcomes, with disease duration being a key predictor of success. No significant difference ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results